Mail Us
Reverse Engineering Analysis
Types of Analysis
- Thermal Analysis
- Material Characterization
- Mechanical Properties Analysis
- Polymer Composition Analysis
- Polymer Additives Analysis
- Thin Film Analysis
- Material Degradation Analysis
- Quality Control of Engineering Parts
- Failure and Stress Analysis
- Analysis of Construction and Building Materials
- Mining and Metallurgy Analysis
- Corrosion Analysis
- Reverse Engineering Analysis
- Permeability and Transmission Rate Analysis
- Microstructure Analysis
Reverse Engineering Analysis
Reverse engineering in pharmaceuticals involves meticulously analyzing existing drug formulations to decipher their composition, manufacturing processes, and mechanisms of action. This complex process employs advanced analytical techniques such as high-performance liquid chromatography (HPLC) , mass spectrometry (MS) , Confocal Raman Spectroscopy and nuclear magnetic resonance (NMR) spectroscopy to accurately identify and quantify the active pharmaceutical ingredients (APIs) and excipients. By understanding these components and their interactions within the formulation, pharmaceutical companies can develop high-quality generic versions of branded drugs. This not only ensures that more affordable medication options are available but also maintains the efficacy and safety of the original products.
The process of reverse engineering also involves rigorous adherence to regulatory guidelines set by authorities like the FDA and EMA. Companies must conduct extensive testing and validation to demonstrate that their generic products are bioequivalent to the original branded drugs, ensuring they meet strict standards for safety, efficacy, and quality. This approach enhances research and development efforts, leading to the creation of improved formulations and innovative delivery methods. Ultimately, reverse engineering in pharmaceuticals plays a crucial role in expanding access to essential medications, driving down healthcare costs, and fostering a competitive market that benefits patients worldwide.